Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients.
Rigolin GM, Saccenti E, Rizzotto L, Ferracin M, Martinelli S, Formigaro L, Cibien F, Cavallari M, Lista E, Daghia G, Sofritti O, Ciccone M, Cavazzini F, Lupini L, Bassi C, Zagatti B, Negrini M, Cuneo A.
Rigolin GM, et al. Among authors: daghia g.
Oncotarget. 2014 Jan 15;5(1):140-9. doi: 10.18632/oncotarget.1382.
Oncotarget. 2014.
PMID: 24334759
Free PMC article.